These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 1686200)

  • 1. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents.
    Njung'e K; Handley SL
    Br J Pharmacol; 1991 Sep; 104(1):105-12. PubMed ID: 1686200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
    Arnt J
    Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of serotonergic mechanisms in inhibition of isolation-induced aggression in male mice.
    Sánchez C; Arnt J; Hyttel J; Moltzen EK
    Psychopharmacology (Berl); 1993; 110(1-2):53-59. PubMed ID: 7870899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice.
    Ichimaru Y; Egawa T; Sawa A
    Jpn J Pharmacol; 1995 May; 68(1):65-70. PubMed ID: 7494384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder.
    Matsushita M; Egashira N; Harada S; Okuno R; Mishima K; Iwasaki K; Nishimura R; Fujiwara M
    J Pharmacol Sci; 2005 Oct; 99(2):154-9. PubMed ID: 16210777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents.
    Simansky KJ; Schechter LE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1073-81. PubMed ID: 3144595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of alpha 2-adrenoceptor antagonists on the inhibition of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced head shakes by 5-HT1A receptor agonists in the mouse.
    Dursun SM; Handley SL
    Br J Pharmacol; 1993 Aug; 109(4):1046-52. PubMed ID: 8104640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
    Berendsen HH; Jenck F; Broekkamp CL
    Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs.
    De Vry J; Benz U; Schreiber R; Traber J
    Eur J Pharmacol; 1993 Nov; 249(3):331-9. PubMed ID: 7904565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission.
    Chioca LR; Ferro MM; Baretta IP; Oliveira SM; Silva CR; Ferreira J; Losso EM; Andreatini R
    J Ethnopharmacol; 2013 May; 147(2):412-8. PubMed ID: 23524167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box.
    Sánchez C
    Pharmacol Toxicol; 1995 Jul; 77(1):71-8. PubMed ID: 8532615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1987 Jun; 138(1):29-36. PubMed ID: 2887435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.